Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells

In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated...

Full description

Saved in:
Bibliographic Details
Published inJournal of experimental & clinical cancer research Vol. 38; no. 1; pp. 389 - 14
Main Authors Mao, Yu, Wang, Yimin, Dong, Lixin, Zhang, Yunjie, Zhang, Yanqiu, Wang, Chao, Zhang, Qiang, Yang, Sen, Cao, Liyan, Zhang, Xinyuan, Li, Xin, Fu, Zhanzhao
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 05.09.2019
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN1756-9966
0392-9078
1756-9966
DOI10.1186/s13046-019-1384-8

Cover

Loading…
Abstract In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC.
AbstractList In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC.
In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC.
Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Methods Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Results Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Conclusions Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC.
Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Methods Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Results Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Conclusions Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC. Keywords: ESCC, Angiogensis, Exosomes, Metastasis
Abstract Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Methods Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Results Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Conclusions Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC.
In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC).BACKGROUNDIn cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC).Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs.METHODSDifferential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs.Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs.RESULTSExosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs.Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC.CONCLUSIONSTaken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC.
ArticleNumber 389
Audience Academic
Author Cao, Liyan
Zhang, Xinyuan
Wang, Chao
Zhang, Qiang
Zhang, Yanqiu
Wang, Yimin
Mao, Yu
Zhang, Yunjie
Dong, Lixin
Yang, Sen
Li, Xin
Fu, Zhanzhao
Author_xml – sequence: 1
  givenname: Yu
  surname: Mao
  fullname: Mao, Yu
– sequence: 2
  givenname: Yimin
  surname: Wang
  fullname: Wang, Yimin
– sequence: 3
  givenname: Lixin
  surname: Dong
  fullname: Dong, Lixin
– sequence: 4
  givenname: Yunjie
  surname: Zhang
  fullname: Zhang, Yunjie
– sequence: 5
  givenname: Yanqiu
  surname: Zhang
  fullname: Zhang, Yanqiu
– sequence: 6
  givenname: Chao
  surname: Wang
  fullname: Wang, Chao
– sequence: 7
  givenname: Qiang
  surname: Zhang
  fullname: Zhang, Qiang
– sequence: 8
  givenname: Sen
  surname: Yang
  fullname: Yang, Sen
– sequence: 9
  givenname: Liyan
  surname: Cao
  fullname: Cao, Liyan
– sequence: 10
  givenname: Xinyuan
  surname: Zhang
  fullname: Zhang, Xinyuan
– sequence: 11
  givenname: Xin
  surname: Li
  fullname: Li, Xin
– sequence: 12
  givenname: Zhanzhao
  surname: Fu
  fullname: Fu, Zhanzhao
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31488217$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1r1zAUxotM3It-AG8kIIg3nUnavPRGGEPdYOCNXoc0PW0z2qRLUtk-j1_UdP859xeRFpqcPs_vJIfnuDhw3kFRvCb4lBDJP0RS4ZqXmDQlqWRdymfFERGMl03D-cGT9WFxHOM1xpw0pHlRHFaklpIScVT8vLhb_K01CG599DNE1GtjJ5t0AqTdYP0ADqKNedOhGZKO-c1b6xBEv4x6AD2heLPq2a8RGZgmZHQw1vlZozQGvw4j0lOCYN2QC4CWEZxPdwvcM1PQLppgl5TbI98jcJ3Psslm7oaLL4vnvZ4ivHr4nhTfP3_6dn5RXn39cnl-dlUa1pBUcs5rzQSVVWeqhkJfQ2VAmJYaRoBIKXBbs7qjrWEdp0xXRLatpBiw0Kyuq5PicsftvL5WS7CzDnfKa6vuCz4MSodkzQRKdpR0hEJDKdSsw20rsDCUmYYTXFGaWR93rGVtZ-gMuHzPaQ-6_8fZUQ3-h-KCCiZZBrx_AAR_s0JMarZxG4d2kAetKJW8IZSL7dxv_5Je-zW4PKqsamjDmZT8j2rQ-QLW9T73NRtUnXGMaQYKkVWn_1Dlp4PZmhy_3ub6nuHdE8OYw5DG6Kc1We_ivvDN04k8juJ3FrOA7AQm-BgD9I8SgtWWd7XLu8p5V1velcwe8ZfHbNHNvfOx7fQf5y9GGAXK
CitedBy_id crossref_primary_10_1007_s10456_021_09819_0
crossref_primary_10_1186_s12964_020_00541_w
crossref_primary_10_1186_s12967_020_02662_9
crossref_primary_10_1016_j_critrevonc_2022_103702
crossref_primary_10_1073_pnas_2200252119
crossref_primary_10_4251_wjgo_v16_i4_1578
crossref_primary_10_1111_cas_15801
crossref_primary_10_1016_j_canlet_2022_215796
crossref_primary_10_1186_s13045_022_01305_4
crossref_primary_10_3390_ijms21165840
crossref_primary_10_1002_wnan_1989
crossref_primary_10_3390_cancers13174380
crossref_primary_10_1007_s00018_022_04552_3
crossref_primary_10_1016_j_jbo_2020_100280
crossref_primary_10_1016_j_cytogfr_2023_08_010
crossref_primary_10_1038_s41420_024_01905_8
crossref_primary_10_2147_IJN_S321555
crossref_primary_10_3390_cancers14081969
crossref_primary_10_1016_j_mvr_2021_104297
crossref_primary_10_3390_ijms21145071
crossref_primary_10_3390_cancers14030536
crossref_primary_10_1186_s12929_020_00654_x
crossref_primary_10_3748_wjg_v29_i42_5699
crossref_primary_10_3389_fmolb_2021_703640
crossref_primary_10_1080_00365521_2024_2310167
crossref_primary_10_1177_09636897221106998
crossref_primary_10_1016_j_bbcan_2020_188497
crossref_primary_10_2147_CMAR_S258215
crossref_primary_10_3389_fphys_2020_579892
crossref_primary_10_1080_21655979_2022_2060720
crossref_primary_10_3390_biomedicines11092534
crossref_primary_10_1186_s13046_023_02821_y
crossref_primary_10_1186_s12967_022_03649_4
crossref_primary_10_2174_1566524022666220321125134
crossref_primary_10_3390_ijms231911789
crossref_primary_10_1021_acsabm_4c00660
crossref_primary_10_1186_s12935_024_03314_4
crossref_primary_10_15252_embj_2021109288
crossref_primary_10_3389_fimmu_2022_824188
crossref_primary_10_1155_2022_5209607
crossref_primary_10_2147_IJN_S479533
crossref_primary_10_3390_jcm9020436
crossref_primary_10_1016_j_phrs_2023_106669
crossref_primary_10_1080_21655979_2021_1974765
crossref_primary_10_1016_j_jconrel_2023_09_034
crossref_primary_10_1016_j_omtn_2023_05_002
crossref_primary_10_1186_s12935_021_02026_3
crossref_primary_10_3390_life12040524
crossref_primary_10_3389_fbioe_2022_772514
crossref_primary_10_3390_cells10123429
crossref_primary_10_3390_ijms241411344
crossref_primary_10_3389_fonc_2021_638357
crossref_primary_10_1007_s13577_024_01068_9
crossref_primary_10_1016_j_lfs_2019_117176
crossref_primary_10_1007_s12094_024_03815_8
crossref_primary_10_1002_cam4_6007
crossref_primary_10_1186_s41983_023_00635_5
crossref_primary_10_1007_s13238_021_00863_6
crossref_primary_10_1016_j_bbcan_2024_189244
crossref_primary_10_1186_s12943_021_01440_5
crossref_primary_10_1016_j_tice_2022_101814
crossref_primary_10_1007_s12672_024_00879_4
crossref_primary_10_1097_CAD_0000000000000961
crossref_primary_10_2174_0115680266304636240626055711
crossref_primary_10_1166_jbt_2022_2896
crossref_primary_10_3389_fcell_2020_611039
crossref_primary_10_1021_acs_jnatprod_2c00457
crossref_primary_10_2147_CMAR_S327621
crossref_primary_10_2144_fsoa_2021_0102
crossref_primary_10_1159_000508302
crossref_primary_10_1186_s12951_022_01609_0
crossref_primary_10_3390_cells10102617
crossref_primary_10_3389_fphar_2023_1172908
crossref_primary_10_4251_wjgo_v13_i5_312
crossref_primary_10_1016_j_gde_2020_12_018
crossref_primary_10_1016_j_lfs_2020_117761
crossref_primary_10_1002_cam4_5002
crossref_primary_10_1021_acs_molpharmaceut_3c00488
crossref_primary_10_1073_pnas_1918086116
crossref_primary_10_1002_1878_0261_12902
crossref_primary_10_1186_s12935_021_01943_7
crossref_primary_10_3389_fonc_2021_732702
crossref_primary_10_1021_acs_bioconjchem_3c00232
crossref_primary_10_1186_s12964_023_01142_z
crossref_primary_10_3892_ijo_2023_5530
Cites_doi 10.1016/j.canlet.2015.10.011
10.1177/1010428317698383
10.1038/s41417-018-0032-3
10.1111/cas.14122
10.1016/S0140-6736(12)60643-6
10.3892/ijo.2016.3453
10.1186/s12943-018-0869-y
10.1002/cbf.3276
10.1016/j.canlet.2017.06.027
10.1038/s41467-017-01647-5
10.1007/s12307-013-0142-2
10.1073/pnas.1220998110
10.1186/s12943-019-0995-1
10.12688/f1000research.9118.1
10.1016/j.trecan.2017.05.002
10.1038/nature04871
10.2174/1566524018666181004115304
10.1038/ncb1596
10.1038/s41598-018-27307-2
10.18632/oncotarget.9981
10.1038/ncomms7999
10.3892/or.2014.2986
10.12998/wjcc.v7.i8.908
10.1038/nature05760
10.1038/onc.2017.105
10.1007/s10456-017-9562-9
10.1186/s12943-017-0714-8
10.1111/j.1467-985X.2010.00676_9.x
10.1158/0008-5472.CAN-17-0994
10.1111/joim.12019
10.1002/wics.147
10.1101/gr.1239303
10.1007/978-1-59745-241-0_17
10.1038/ncomms10818
10.1089/dna.2018.4533
10.1111/cas.13336
10.1186/s12943-019-0949-7
10.3322/caac.21387
10.1016/j.tips.2016.04.006
10.1016/j.jconrel.2015.06.029
10.1002/mc.22238
10.1373/clinchem.2015.240028
10.1038/nrc.2017.51
10.1097/PPO.0000000000000138
10.1186/1471-2407-12-421
10.3892/or.2017.5453
10.1146/annurev-cellbio-092910-154002
10.1186/s13046-018-0845-9
10.1002/jcp.27429
10.1007/s10555-010-9224-5
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13046-019-1384-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

Publicly Available Content Database



MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-9966
EndPage 14
ExternalDocumentID oai_doaj_org_article_8d21d12e922e45d0bb707c25c9610322
PMC6727585
A600222877
31488217
10_1186_s13046_019_1384_8
Genre Journal Article
GrantInformation_xml – fundername: Scientific Research Fund of Hebei Health and Family Planning Commission
  grantid: 20181192
– fundername: ;
  grantid: 20181192
GroupedDBID ---
0R~
29K
2WC
4.4
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
D-I
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
ESX
F5P
FYUFA
GROUPED_DOAJ
H13
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c591t-6664a57283dc392ef4e3ce7cb2c51e18870b454d2bc5d625a318bb820e07a5443
IEDL.DBID M48
ISSN 1756-9966
0392-9078
IngestDate Wed Aug 27 01:30:50 EDT 2025
Thu Aug 21 18:17:58 EDT 2025
Sun Aug 24 03:44:45 EDT 2025
Sat Aug 23 13:36:52 EDT 2025
Tue Jun 17 21:25:19 EDT 2025
Tue Jun 10 20:18:10 EDT 2025
Thu May 22 21:21:21 EDT 2025
Thu Apr 03 07:03:22 EDT 2025
Thu Apr 24 22:55:38 EDT 2025
Tue Jul 01 02:26:37 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Angiogensis
Metastasis
Exosomes
ESCC
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c591t-6664a57283dc392ef4e3ce7cb2c51e18870b454d2bc5d625a318bb820e07a5443
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2292965886?pq-origsite=%requestingapplication%
PMID 31488217
PQID 2292965886
PQPubID 105475
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_8d21d12e922e45d0bb707c25c9610322
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6727585
proquest_miscellaneous_2286912674
proquest_journals_2292965886
gale_infotracmisc_A600222877
gale_infotracacademiconefile_A600222877
gale_healthsolutions_A600222877
pubmed_primary_31488217
crossref_primary_10_1186_s13046_019_1384_8
crossref_citationtrail_10_1186_s13046_019_1384_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-09-05
PublicationDateYYYYMMDD 2019-09-05
PublicationDate_xml – month: 09
  year: 2019
  text: 2019-09-05
  day: 05
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of experimental & clinical cancer research
PublicationTitleAlternate J Exp Clin Cancer Res
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References EC Finger (1384_CR32) 2010; 29
RL Siegel (1384_CR1) 2017; 67
L Milane (1384_CR9) 2015; 219
Z Zhong (1384_CR49) 2017; 403
T Shen (1384_CR51) 2017; 37
1384_CR24
HW King (1384_CR35) 2012; 12
J Pasquier (1384_CR40) 2014; 7
Y Mao (1384_CR22) 2016; 7
X Ma (1384_CR44) 2017; 8
J Liao (1384_CR17) 2016; 48
DC Allen (1384_CR2) 2013; 381
P Kucharzewska (1384_CR19) 2013; 110
C Ginestet (1384_CR26) 2011; 174
H Valadi (1384_CR10) 2007; 9
P Shannon (1384_CR29) 2003; 13
C Viallard (1384_CR5) 2017; 20
M Kang (1384_CR12) 2018; 37
S Damian (1384_CR27) 2015; 43
S Rey (1384_CR6) 2017; 3
NJ Taylor (1384_CR47) 2015; 54
H Shao (1384_CR42) 2015; 6
T Muetze (1384_CR28) 2016; 5
MC Lowry (1384_CR11) 2015; 61
Yu Mao (1384_CR18) 2019; 110
H Wickham (1384_CR25) 2015; 3
L Claesson-Welsh (1384_CR48) 2013; 273
J Pouyssegur (1384_CR31) 2006; 441
CF Ruivo (1384_CR14) 2017; 77
Y Mao (1384_CR20) 2018; 8
W Wang (1384_CR52) 2017; 39
AS Chung (1384_CR8) 2011; 27
LL Su (1384_CR15) 2019; 7
Y Du (1384_CR50) 2018; 18
Y Mao (1384_CR21) 2019; 234
M Xue (1384_CR30) 2017; 16
Y Liu (1384_CR33) 2016; 370
KM Malinda (1384_CR23) 2009; 467
Y Guo (1384_CR38) 2019; 18
GP Gupta (1384_CR39) 2007; 446
L Jia (1384_CR45) 2016; 7
YL Cao (1384_CR41) 2017; 35
N Syn (1384_CR34) 2016; 37
M De Palma (1384_CR7) 2017; 17
N Maishi (1384_CR37) 2017; 108
YL Hsu (1384_CR43) 2017; 36
Z Jiang (1384_CR46) 2014; 31
L Mao (1384_CR13) 2018; 25
D Predescu (1384_CR3) 2012; 107
C Shao (1384_CR36) 2018; 17
DR Bielenberg (1384_CR4) 2015; 21
W Li (1384_CR16) 2019; 18
References_xml – volume: 370
  start-page: 125
  issue: 1
  year: 2016
  ident: 1384_CR33
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.10.011
– volume: 39
  start-page: 101042831769838
  issue: 6
  year: 2017
  ident: 1384_CR52
  publication-title: Tumour Biol
  doi: 10.1177/1010428317698383
– volume: 25
  start-page: 248
  issue: 9–10
  year: 2018
  ident: 1384_CR13
  publication-title: Cancer Gene Ther
  doi: 10.1038/s41417-018-0032-3
– volume: 110
  start-page: 2700
  issue: 9
  year: 2019
  ident: 1384_CR18
  publication-title: Cancer Science
  doi: 10.1111/cas.14122
– volume: 381
  start-page: 400
  issue: 9864
  year: 2013
  ident: 1384_CR2
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(12)60643-6
– volume: 48
  start-page: 2567
  issue: 6
  year: 2016
  ident: 1384_CR17
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2016.3453
– volume: 17
  start-page: 120
  issue: 1
  year: 2018
  ident: 1384_CR36
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0869-y
– volume: 35
  start-page: 296
  issue: 6
  year: 2017
  ident: 1384_CR41
  publication-title: Cell Biochem Funct
  doi: 10.1002/cbf.3276
– volume: 403
  start-page: 305
  year: 2017
  ident: 1384_CR49
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2017.06.027
– volume: 8
  start-page: 1506
  issue: 1
  year: 2017
  ident: 1384_CR44
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01647-5
– volume: 7
  start-page: 41
  issue: 1–2
  year: 2014
  ident: 1384_CR40
  publication-title: Cancer Microenvironment
  doi: 10.1007/s12307-013-0142-2
– volume: 110
  start-page: 7312
  issue: 18
  year: 2013
  ident: 1384_CR19
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1220998110
– volume: 18
  start-page: 39
  issue: 1
  year: 2019
  ident: 1384_CR38
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-0995-1
– volume: 5
  start-page: 1745
  year: 2016
  ident: 1384_CR28
  publication-title: F1000Research
  doi: 10.12688/f1000research.9118.1
– volume: 3
  start-page: 529
  issue: 7
  year: 2017
  ident: 1384_CR6
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2017.05.002
– volume: 441
  start-page: 437
  issue: 7092
  year: 2006
  ident: 1384_CR31
  publication-title: Nature.
  doi: 10.1038/nature04871
– volume: 18
  start-page: 273
  issue: 5
  year: 2018
  ident: 1384_CR50
  publication-title: Curr Mol Med
  doi: 10.2174/1566524018666181004115304
– volume: 9
  start-page: 654
  issue: 6
  year: 2007
  ident: 1384_CR10
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1596
– volume: 8
  start-page: 8823
  issue: 1
  year: 2018
  ident: 1384_CR20
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-27307-2
– volume: 7
  start-page: 51223
  issue: 32
  year: 2016
  ident: 1384_CR22
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.9981
– volume: 6
  start-page: 6999
  year: 2015
  ident: 1384_CR42
  publication-title: Nat Commun
  doi: 10.1038/ncomms7999
– volume: 31
  start-page: 1249
  issue: 3
  year: 2014
  ident: 1384_CR46
  publication-title: Oncol Rep
  doi: 10.3892/or.2014.2986
– volume: 7
  start-page: 908
  issue: 8
  year: 2019
  ident: 1384_CR15
  publication-title: World J Clin Cases
  doi: 10.12998/wjcc.v7.i8.908
– volume: 43
  start-page: D447
  issue: Database issue
  year: 2015
  ident: 1384_CR27
  publication-title: Nucleic Acids Res
– volume: 446
  start-page: 765
  issue: 7137
  year: 2007
  ident: 1384_CR39
  publication-title: Nature.
  doi: 10.1038/nature05760
– volume: 36
  start-page: 4929
  issue: 34
  year: 2017
  ident: 1384_CR43
  publication-title: Oncogene.
  doi: 10.1038/onc.2017.105
– volume: 20
  start-page: 409
  issue: 4
  year: 2017
  ident: 1384_CR5
  publication-title: Angiogenesis.
  doi: 10.1007/s10456-017-9562-9
– volume: 16
  start-page: 143
  issue: 1
  year: 2017
  ident: 1384_CR30
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0714-8
– volume: 174
  start-page: 245
  issue: 1
  year: 2011
  ident: 1384_CR26
  publication-title: J R Stat Soc
  doi: 10.1111/j.1467-985X.2010.00676_9.x
– volume: 107
  start-page: 583
  issue: 5
  year: 2012
  ident: 1384_CR3
  publication-title: Chirurgia (Bucharest, Romania : 1990)
– volume: 77
  start-page: 6480
  issue: 23
  year: 2017
  ident: 1384_CR14
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-0994
– volume: 273
  start-page: 114
  issue: 2
  year: 2013
  ident: 1384_CR48
  publication-title: J Intern Med
  doi: 10.1111/joim.12019
– volume: 3
  start-page: 180
  issue: 2
  year: 2015
  ident: 1384_CR25
  publication-title: Wiley Interdisciplinary Rev Comp Stat
  doi: 10.1002/wics.147
– volume: 13
  start-page: 2498
  issue: 11
  year: 2003
  ident: 1384_CR29
  publication-title: Genome Res
  doi: 10.1101/gr.1239303
– volume: 467
  start-page: 287
  year: 2009
  ident: 1384_CR23
  publication-title: Methods Mole Biol (Clifton, NJ)
  doi: 10.1007/978-1-59745-241-0_17
– volume: 7
  start-page: 10818
  year: 2016
  ident: 1384_CR45
  publication-title: Nat Commun
  doi: 10.1038/ncomms10818
– ident: 1384_CR24
  doi: 10.1089/dna.2018.4533
– volume: 108
  start-page: 1921
  issue: 10
  year: 2017
  ident: 1384_CR37
  publication-title: Cancer Sci
  doi: 10.1111/cas.13336
– volume: 18
  start-page: 22
  issue: 1
  year: 2019
  ident: 1384_CR16
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-0949-7
– volume: 67
  start-page: 7
  issue: 1
  year: 2017
  ident: 1384_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21387
– volume: 37
  start-page: 606
  issue: 7
  year: 2016
  ident: 1384_CR34
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2016.04.006
– volume: 219
  start-page: 278
  year: 2015
  ident: 1384_CR9
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2015.06.029
– volume: 54
  start-page: 1668
  issue: 12
  year: 2015
  ident: 1384_CR47
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22238
– volume: 61
  start-page: 1457
  issue: 12
  year: 2015
  ident: 1384_CR11
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2015.240028
– volume: 17
  start-page: 457
  issue: 8
  year: 2017
  ident: 1384_CR7
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2017.51
– volume: 21
  start-page: 267
  issue: 4
  year: 2015
  ident: 1384_CR4
  publication-title: Cancer J
  doi: 10.1097/PPO.0000000000000138
– volume: 12
  start-page: 421
  issue: 1
  year: 2012
  ident: 1384_CR35
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-12-421
– volume: 37
  start-page: 2095
  issue: 4
  year: 2017
  ident: 1384_CR51
  publication-title: Oncol Rep
  doi: 10.3892/or.2017.5453
– volume: 27
  start-page: 563
  year: 2011
  ident: 1384_CR8
  publication-title: Annu Rev Cell Dev Biol
  doi: 10.1146/annurev-cellbio-092910-154002
– volume: 37
  start-page: 171
  issue: 1
  year: 2018
  ident: 1384_CR12
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-0845-9
– volume: 234
  start-page: 6810
  issue: 5
  year: 2019
  ident: 1384_CR21
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.27429
– volume: 29
  start-page: 285
  issue: 2
  year: 2010
  ident: 1384_CR32
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-010-9224-5
SSID ssj0061919
Score 2.5162363
Snippet In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the...
Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt...
Abstract Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 389
SubjectTerms Angiogenesis
Angiogensis
Animals
Cancer cells
Cancer metastasis
Carcinoma
Care and treatment
Cell Cycle
Cell Line, Tumor
Computational Biology - methods
Development and progression
Disease Models, Animal
Disease Progression
DNA microarrays
Electron microscopy
Endothelial Cells
Endothelium
ESCC
Esophageal cancer
Esophageal Squamous Cell Carcinoma - genetics
Esophageal Squamous Cell Carcinoma - metabolism
Esophageal Squamous Cell Carcinoma - pathology
Esophagus
Exosomes
Exosomes - metabolism
Gene Expression Profiling
Genetic aspects
Humans
Hypoxia
Hypoxia - genetics
Hypoxia - metabolism
Metastasis
Mice
Microscopy
Molecular Sequence Annotation
Neoplasm Metastasis
Neoplasm Staging
Neovascularization, Pathologic - genetics
Neovascularization, Pathologic - metabolism
Phenotype
Squamous cell carcinoma
Stem cells
Transcription (Genetics)
Transcriptome
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yD-KL-G311AiCIJRr0nw0j6d4LML55MG9hXz1XLht72wPzr_Hf9SZtLtsEfTFxzaTbDcz-c1MJpkh5J3ytRZtLUofDTgotTal0a0pnTOiDt6pEPC-8-lXtToTX87l-V6pLzwTNqUHnibuqImcRcaT4TwJGSvvdaUDl8EozAWX0Rd03taZmjAYvAJm5hgma9TRwDAACG6zwZx7omwWWign6_8Tkvd00vK85J4COnlA7s-WIz2evvghuZO6R-Tu6Rwbf0x-rX5e9bfrQNNtP_SbNNDWhSkHd6Kuu1j3F4hr6wEeIt2k0YFhiI_rjiYsZgDIAuMP1zcOtwMobunTgKWGun7j6FzQh-bwOug7eJEoHhDrcRc3jzmi3ssoBD9P-5amLuIFr0uQ8Tzc8IScnXz-9mlVziUYyiANG0twboSTGmyQGMCSSq1IdUg6eB4kSwwQqvJCish9kBFcKQcQ4T1YFanSDlPrPSUHXd-l54TKSrVR6yhanwSLDky_GESoJYPelXMFqbYssWHOT45lMi5t9lMaZScuWuCiRS7apiAfdl2upuQcfyP-iHzeEWJe7fwCpM3O0mb_JW0FeYNSYqdLqjt0sMcq3yputC7I-0yB-ACfH9x8zQEmATNtLSgPF5SwrsOyeSuJdsaVwXIO5iwYjY0qyNtdM_bEs3JdAvEAmkYZxpUWBXk2Ce7uT9fg_TbghRZEL0R6MSvLlm79PWcdx5A9-JYv_sc0viT3OC5GDMzJQ3Iw_rhJr8C4G_3rvI5_Ay_wTeU
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifls9NYIgCOXaNB_tk5zisQjnkwf7FvLVdeG23bvuwfn3-I86k2brFeEe20zSj5nMzC-TzBDyQdpK8bbiufUNAJRKNXmj2iY3puGVs0Y6h-edT3_IxRn_vhTLtOA2pG2Ve50YFbXvHa6RHzEGhhzMZS0_by9yrBqF0dVUQuMuuYepyxB8qeUEuAAbxMIeYCFljn59imqWtTwaSgwJApBuMAsfz-uZXYrp-_9X0jes1HwH5Q2TdPKIPEy-JD0emf-Y3AndE3L_NEXLn5I_i9_b_nrtaLjuh34TBtoaN2blDtR0q3W_Qk23HuDC003YGXAV8XLd0YDlDUDXwPjDxZXBBQKKi_zUYfGhrt8Ymkr80BhwBwsINwLFLWM9ruvGMXdoCaNegsfTvqWh83jk6xykPg43PCNnJ99-fl3kqShD7kRT7nKAO9wIBV6Jd-BbhZaHygXlLHOiDCXorMJywT2zTngAVwaUhrXgZ4RCGUy295wcdH0XXhIqCtl6pTxvbeClN-AMesddJUroXRiTkWLPEu1SxnIsnHGuI3KppR65qIGLGrmo64x8mrpsx3QdtxF_QT5PhJhpO97oL1c6TVxde1b6koWGscCFL6xVhXJMuEZiLkKWkXcoJXo8tjrpC30s4znjWqmMfIwUqDHg9Z1JBx_gJ2DurRnl4YwSZrqbN-8lUSdNM-h_8yIj76dm7Im757oA4gE0tWxKJhXPyItRcKePrgAP14BLM6JmIj37K_OWbv0r5iHHID6gzVe3v9Zr8oDhNMMgnDgkB7vLq_AGHLmdfRtn61-xWkie
  priority: 102
  providerName: ProQuest
Title Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells
URI https://www.ncbi.nlm.nih.gov/pubmed/31488217
https://www.proquest.com/docview/2292965886
https://www.proquest.com/docview/2286912674
https://pubmed.ncbi.nlm.nih.gov/PMC6727585
https://doaj.org/article/8d21d12e922e45d0bb707c25c9610322
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1ba9swFBa9wNjL2H3eukyDwWDgzZZly34YoxktYZAyygJlL0I3Z4HEbuMU0t-zP7pzZMfUrGwvAVtHSiKd26cjnUPIu0wngpcJD7UtAKAkoggLURahUgVPjFaZMXjfeXqWTWb820V6sUd25a26CWzuhHZYT2q2Xn7cXt18AYH_7AU-zz41MYb3ABQXmFGPh_k-OQTDJLCSw5T3QQWACr7ORwQuQQiYMO-CnHcOMTBTPpv_3zr7ltEaHqi8ZaFOH5IHnWtJj1teeET2XPWY3Jt2wfMn5Pfk5rLeLgx127qpV66hpTJtkm5HVTVf1HNUfIsGHixduY0CzxEfFxV1WO0AVA-M31xdK9wvoLjnTw3WIqrqlaJdxR_q4-9gEOGFo3iCrMZtXj_mBg2jV1Pw9bQuqass3gBbghD44ZqnZHZ68uPrJOxqNIQmLeJNCOiHq1SAk2INzKsruUuME0Yzk8YuBhUWaZ5yy7RJLWAtBTpEa3A7XCQU5t57Rg6qunIvCE2jrLRCWF5qx2OrwDe0hpskjaF3pFRAot2SSNMlMMc6GkvpgUyeyXYVJayixFWUeUA-9F0u2-wd_yIe4zr3hJh427-o13PZybHMLYttzFzBmOOpjbQWkTAsNUWGqQlZQN4gl8j2FmuvPuRx5q8d50IE5L2nQJaGn29Udw8CJgFTcQ0ojwaUIPhm2LzjRLmTG8kY-LvgVeZZQN72zdgTD9NVDtgDaPKsiFkmeECet4zb_-kE4HEOMDUgYsDSg1kZtlSLXz4tOcb0AXy-_O8MvCL3GUoahuXSI3KwWV-71-DabfSI7IsLMSKH45Oz7-cjv0Ey8kIMn-fjn38A6O9RDQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwEviP8EBjMSCAkpWuI4dvKA0AabOrZOCG3S3jzHdkqlNemWTmyfh3c-I3dOWhYh7W2PSc5umjv_7s7nuyPknSgSycuEh4XNwUFJZB7mssxDrXOemEILYzDfeXQghkf823F6vEL-LHJh8FjlAhM9UNva4B75BmOgyEFdZuLz7CzErlEYXV200GjFYs9d_QKXrfm0-xX4-56xne3DL8Ow6yoQmjSP5yHY61ynEtSqNWAcuJK7xDhpCmbS2MWw6KKCp9yywqQWvAMNUl8UoChdJDVWi4N575BVnoCpMCCrW9sH338ssB-8Ed9KBHSyCNGT6OKocSY2mhiDkOC651j3j4dZTxP6hgH_q4VrerF_ZvOaEtx5SB501ivdbMXtEVlx1WNyd9TF55-Q38OrWX05MdRd1k09dQ0ttWnrgDuqq_GkHiO2Thq4sHTq5hqMU7ycVNRhQwVAN5i_ObvQuCVBMaxADbY7quqppl1TIepD_KBz4YajeEitxp1kP-ccda9HQvh5WpfUVRaTzE5hnfnpmqfk6FYY9owMqrpyLwhNI1FaKS0vC8djq8H8tIabJI1hdKR1QKIFS5TpaqRjq45T5X2lTKiWiwq4qJCLKgvIx-WQWVsg5CbiLeTzkhBre_sb9flYdVChMstiGzOXM-Z4aqOikJE0LDW5wOqHLCDrKCWqTZRdIpTaFD6zOZMyIB88BWIUvL7RXaoFfASs9tWjXOtRAraY_uOFJKoO2xr1byUG5O3yMY7E83qVA_EAmkzkMROSB-R5K7jLP52AB56BJxwQ2RPp3lfpP6kmP33lczw2AP7ty5tfa53cGx6O9tX-7sHeK3Kf4ZLDEGC6Rgbz8wv3GszIefGmW7uUnNw2XPwFMUyF2Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxic+exosomes+facilitate+angiogenesis+and+metastasis+in+esophageal+squamous+cell+carcinoma+through+altering+the+phenotype+and+transcriptome+of+endothelial+cells&rft.jtitle=Journal+of+experimental+%26+clinical+cancer+research&rft.au=Wang%2C+Chao&rft.au=Zhang%2C+Xinyuan&rft.au=Dong%2C+Lixin&rft.au=Yang%2C+Sen&rft.date=2019-09-05&rft.pub=BioMed+Central+Ltd&rft.issn=0392-9078&rft.volume=38&rft.issue=1&rft_id=info:doi/10.1186%2Fs13046-019-1384-8&rft.externalDBID=n%2Fa&rft.externalDocID=A600222877
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-9966&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-9966&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-9966&client=summon